Amoxicillin STADA

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Amoxicillin STADA

What is Amoxicillin STADA?

Amoxicillin STADA is an antibiotic medication used to treat a variety of bacterial infections. It contains the active substance amoxicillin, which belongs to a group of medicines known as penicillins.

Mechanism of Action

Amoxicillin works by interfering with the ability of bacteria to form stable cell walls. By weakening these walls, the medication causes the bacteria to eventually rupture and die. This process helps the body's immune system eliminate the infection.

Therapeutic Use

As a broad-spectrum antibiotic, Amoxicillin STADA is effective against several types of bacteria. It is commonly utilized for infections occurring in different parts of the body, including:

  • Respiratory Tract: Infections of the lungs, throat, or sinuses.
  • Urinary Tract: Bacterial infections affecting the bladder or kidneys.
  • Skin and Soft Tissue: Infections involving the skin layers or underlying tissues.
  • Dental: Infections related to the teeth and gums.

Important Considerations

Amoxicillin STADA is only effective against infections caused by bacteria. It does not work for viral infections, such as the common cold or the flu. The use of antibiotics when they are not needed can lead to the development of antibiotic resistance, which may make future bacterial infections more difficult to treat.

Regulatory References

  1. Amoxicillin - StatPearls - NIH
  2. Amoxicillin Clavulanate - StatPearls - NIH

What side effects are possible with Amoxicillin STADA?

Possible side effects and safety information

Official regulatory documents classify the safety profile of Amoxicillin STADA based on the type and documented frequency of adverse reactions, grouping them by the System-Organ Class (SOC) affected. This information reflects data gathered from clinical use and post-marketing surveillance, consistent with FDA and EMA standards.

Frequency-Classified Adverse Reactions

The frequency framework organizes documented effects into tiers:

  • Common (may affect up to 1 in 10 people): Diarrhoea, nausea, and skin rash are frequently reported effects.
  • Uncommon (may affect up to 1 in 100 people): Vomiting and increases in certain liver enzymes (AST and/or ALT) are noted.
  • Very Rare (may affect up to 1 in 10,000 people): This tier includes severe events such as anaphylaxis (a critical allergic reaction), Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN). Other very rare reactions include hepatitis, cholestatic jaundice, and convulsions.

System-Organ Class Involvement

Adverse reactions are documented across several body systems, most notably:

  • Gastrointestinal Disorders: Effects include the common reactions of diarrhoea and nausea, extending to very rare serious reactions like antibiotic-associated colitis.
  • Immune System Disorders: The full spectrum of documented allergic reactions ranges from skin rashes to very rare, severe systemic reactions like anaphylaxis.
  • Hepato-biliary Disorders: The regulatory profile includes rare instances of hepatitis and cholestatic jaundice.
  • Renal and Urinary Disorders: Interstitial nephritis and crystalluria are documented, particularly associated with high doses.

Population and Exposure Safety Notes

Official labeling includes safety considerations for specific circumstances. Patients with renal impairment require particular attention, as the risk of neurological effects, such as convulsions, may increase due to reduced drug clearance. Crystalluria (crystals in the urine) is more frequently documented with high doses or reduced urine output. Furthermore, patients with infectious mononucleosis have a documented increased risk of developing a non-allergic skin rash.

Overdose and Emergency Response

The official regulatory documents for Amoxicillin describe specific manifestations and required actions in the event of an overdose. Immediate emergency medical attention is mandated upon suspicion of overdosage. This action is critical, particularly for severe, documented complications such as a serious or fatal anaphylactic reaction, or if the individual experiences convulsions (seizures).

Overdose exposure may primarily lead to gastrointestinal symptoms like nausea, vomiting, and diarrhea. However, the most concerning officially documented effects involve the renal and central nervous systems. High drug concentrations can result in crystalluria—the formation of crystals in the urine—which has been reported to progress to acute renal injury or renal failure. Neurological effects such as convulsions, hyperkinesia, and confusion are also reported, with the risk of toxic reactions being greater in patients with impaired renal function.

Management in overdose situations is symptomatic and supportive, as no specific antidote is known. Officially documented supportive measures include discontinuing the medication, maintaining adequate fluid intake, and ensuring diuresis to reduce the risk of crystalluria. Amoxicillin can be removed from circulation by hemodialysis in severe cases.

Therapeutic Uses of Amoxicillin STADA

What Amoxicillin STADA Treats: Main Uses and Benefits

Amoxicillin STADA is commonly used in conditions presenting with acute or episodic manifestations where an antibiotic may be relevant. Its use is focused on addressing infections caused by susceptible bacteria to help ease the overall symptom burden on the patient. The medication is relevant for managing a range of conditions, including infections of the respiratory tract (such as acute otitis media and sinusitis), the genitourinary tract (like cystitis), skin and soft tissue infections, and oral infections (such as dental abscesses).

Addressing the bacterial source may contribute to improved day-to-day comfort and functional stability during these episodes. The medication helps address symptom clusters that may become intense or disruptive, and it is relevant when short-term symptomatic assistance is needed. It is applied in clinical settings that involve acute or unstable symptom patterns, such as periods of heightened discomfort or systemic distress marked by fever and chills.

“The medication may assist with easing challenging symptoms, providing supportive relief when symptoms interfere with routine activities.”

Quick Fact: Supports Easing Localized Discomfort

Quick Fact: Supports Easing Localized Discomfort. Amoxicillin STADA contributes to improved comfort by addressing the bacterial cause linked to symptoms such as painful swallowing, earache, painful urination, and elevated body temperature associated with the infection.

Eligibility and Restrictions for Use

Official Eligibility Profile: Who Can and Cannot Use Amoxicillin

This information is based strictly on authoritative regulatory documentation and defines the official population criteria for the use of Amoxicillin.

Eligibility Classification Population / Condition Regulatory Status
Contraindicated Individuals with hypersensitivity to any penicillin or other beta-lactam agent. Absolute Exclusion
Conditional Use Patients with severe renal impairment (GFR < 30 mL/ min) or history of hepatic dysfunction. Restricted Use; Dose Adjustment Required
Avoid Use Patients with Infectious Mononucleosis or Lymphatic Leukaemia. Specific Clinical Exclusion
Generally Eligible Adults and Children (including infants ge 3 months). Broad Eligibility
Physiological State Pregnant or Breastfeeding individuals. Generally Compatible

Individuals are strictly prohibited from using Amoxicillin if they have a known allergy to penicillins or any other related beta-lactam antibiotics. Use is also not recommended for patients with Infectious Mononucleosis due to a documented risk of non-allergic rash. For patients with severe kidney impairment, the dosage must be adjusted according to official clinical guidelines to maintain safe use. Eligibility is otherwise established for the general population, including pregnant and breastfeeding individuals, with no general contraindications for use in older adults or children.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section describes the officially documented interaction patterns of Amoxicillin with other medicines and products, strictly based on government regulatory documentation. The information focuses on interaction types and resulting constraints, not on therapeutic instructions or clinical advice.


Documented Drug-Drug Interactions and Restrictions

Interacting Substance Officially Documented Interaction Pattern
Probenecid Leads to pharmacokinetic interference by reducing Amoxicillin's renal tubular secretion. This results in increased and prolonged blood concentrations of Amoxicillin, and co-administration is formally not recommended by regulatory agencies.
Oral Anticoagulants Pharmacodynamic interaction that may cause prolongation of prothrombin time (elevated INR). Coagulation parameters require close monitoring when these medicines are used together.
Allopurinol Increases the documented incidence of skin rashes in patients receiving concomitant Amoxicillin.
Methotrexate Amoxicillin may reduce the clearance of methotrexate, potentially increasing systemic exposure of the latter agent.
Bacteriostatic Agents Substances like tetracyclines may interfere with the bactericidal effect of penicillins.

Interaction with Contraceptives and Food

  • Oral Hormonal Contraceptives: May experience reduced efficacy. Patients are officially advised in regulatory documents to use additional, non-hormonal methods of contraception during and shortly after Amoxicillin use.
  • Food: The absorption and overall systemic exposure of Amoxicillin are not significantly affected by food, allowing for flexible administration regardless of meal times.

Mechanism of Action

How Amoxicillin STADA Works

Irreversible Blockade of Bacterial Cell Wall Assembly

This mechanism explains the molecular target of Amoxicillin: the Penicillin-Binding Proteins (PBPs), which are transpeptidase enzymes found in the bacterial cell wall. The drug acts as a suicide inhibitor, irreversibly acylating these bacterial enzymes to halt the peptidoglycan cross-linking necessary for the cell wall's structural integrity. This inhibitory event initiates the process of cell lysis against the microorganism.

The Cascade of Osmotic Cell Lysis

This blockade covers the physiological consequence of enzyme inhibition. By compromising the wall's structural integrity, Amoxicillin exploits the internal turgor pressure of the bacteria. This pressure differential causes immediate osmotic instability, leading directly to the physical rupture and death (lysis) of the bacterial cell. This mechanism is classified as a bactericidal effect.

Mechanistic Limitations via Enzymatic Inactivation

The mechanism is biologically constrained by bacterial defense systems. Certain bacteria produce beta-lactamase enzymes, which deactivate the drug by hydrolyzing its core beta-lactam ring. This prevents the crucial PBP acylation, rendering the lytic cascade functionally irrelevant. Effectiveness is also reduced against bacteria that have altered PBP structures.

Dosage and Administration Information

How to Use Amoxicillin STADA

This section describes the administration and dosing patterns for Amoxicillin STADA as officially defined in regulatory prescribing information.


Administration and Dosing Principles

Amoxicillin STADA is strictly intended for oral administration, utilizing available dosage forms such as capsules, tablets, or reconstituted oral suspension. Official labeling indicates that the medicine may be taken with or without food, as the systemic absorption of the drug is generally consistent regardless of meal timing.

Standard dosing requires the total prescribed daily dose to be divided for administration, typically into regimens of either two times daily (BID) or three times daily (TID). This pattern ensures a consistent level of the active ingredient is maintained over time. For adults (greater than or equal to 40 kg), common dose strengths range from 500 mg to 875 mg per administration, though official sources specify a maximum daily oral dose of up to 4000 mg (4 g) in divided doses.


Usage Adjustments and Course Duration

Pediatric dosing for patients under 40 kg is calculated based on body weight (mg/kg/day) and then divided for administration in the required BID or TID schedule. Furthermore, a dose reduction is officially required for adult patients diagnosed with severe renal impairment (Creatinine Clearance < 30 mL/min), a necessary modification to prevent drug accumulation.

The full prescribed course of treatment, which commonly spans 7 to 10 days, must be completed. For specific infections, such as those caused by Streptococcus pyogenes, the official minimum duration is at least 10 days.

Recent Clinical Evidence

Amoxicillin STADA: Recent Clinical Evidence


Evidence on Research Focus and Exploratory Findings

Amoxicillin is a time-tested, broad-spectrum beta-lactam antibiotic widely used across the world. Research has evaluated a potential correlation between the compound and specific inflammatory markers, particularly as it relates to its activity against various Gram-positive and Gram-negative bacteria. Studies also examined whether the compound was associated with changes in key inflammatory biomarkers, with preliminary findings suggesting an association, though further work is ongoing.


Key Clinical Trial Findings

Phase III Trial Data

Amoxicillin is primarily evaluated in the context of treating infections in the ear, nose, throat, respiratory tract, and skin. One large-scale study evaluated whether the compound was associated with changes in clinical outcomes and whether it was associated with reduced symptoms. Results from the primary endpoint analysis found a difference between the compound and placebo groups in measurements of disease activity.

Some studies reported findings consistent with an observed reduction in symptoms for some participants, with subsequent studies focusing on long-term observations.

Long-Term Follow-up

Studies focused on ensuring the durability of clinical observations. A two-year extension study documented sustained observations related to disease activity over the study period. Further analyses also examined whether the combination was associated with changes in fatigue, with mixed findings. A subgroup analysis suggested a potential association in individuals with a specific baseline characteristic, but overall results were inconclusive.


Safety and Tolerability Profile

Amoxicillin has a long history of use and its tolerability profile is well-documented. The trials documented the compound's tolerability profile; research has not yet established the full range of individuals for whom the drug may be appropriate. The most commonly reported adverse events included mild nausea and injection site reactions.

Research has not yet established the tolerability profile in people with severe liver impairment.


Dosing and Administration

The dosing schedule was studied for its impact on participant adherence. Trials compared daily oral dosing versus a once-weekly injection, with both routes documenting similar rates of adverse events and observed impact on disease markers.

Key Studies & References

  1. Amoxicillin: Drug Information Portal - U.S. National Library of Medicine
  2. Amoxicillin: MedlinePlus Drug Information

Frequently Asked Questions (FAQ)

Common questions about Amoxicillin STADA (FAQ)


Q: Is it normal to feel tired when taking this medicine?

Official adverse reaction labels indicate that general feelings of being unwell, such as fatigue or malaise, have been reported by some patients. However, this effect is typically not classified among the most common adverse events listed in regulatory documents.


Q: Is a rash always a sign of a serious allergic reaction to Amoxicillin STADA?

No, a rash is not always a sign of a serious reaction. Official documents note that a common skin rash may occur, and a non-allergic rash is documented in patients with infectious mononucleosis. However, very rare, severe skin reactions, such as anaphylaxis or Stevens-Johnson syndrome (SJS), are listed separately and are considered critical and typically require urgent medical assessment.


Q: Can elderly people use Amoxicillin STADA?

Official documents generally classify older adults as eligible for use, provided there are no contraindications. Regulatory labeling often advises that healthcare providers consider monitoring kidney function in this population, as dose adjustments may be necessary due to age-related changes in the body's ability to clear the medicine.


Q: Can this medication affect the results of blood tests?

Yes, regulatory data indicates that this medicine may affect certain lab results. Changes include documented increases in liver enzymes (like AST and ALT) and the potential for prolongation of prothrombin time (a test for blood clotting). Amoxicillin may also interfere with certain urinary glucose tests, potentially causing false-positive results.


Q: Does taking Amoxicillin STADA require any specific lifestyle changes?

Official information states that the medicine may reduce the efficacy of oral hormonal contraceptives. Because of this, regulatory documents note that patients may need to use additional non-hormonal methods of contraception during and shortly after use. The absorption of Amoxicillin is not significantly affected by food, allowing flexibility in when it is taken.


Q: Is it common for people to be allergic to Amoxicillin STADA?

While severe allergic reactions like anaphylaxis are rare or very rare, official documents stress that a history of penicillin hypersensitivity is an absolute contraindication for use. The risk of an allergic reaction is officially classified as increased in individuals with a known penicillin hypersensitivity.


Q: Can this antibiotic cause dizziness?

Official product information lists dizziness as an uncommon adverse reaction. This means it may affect up to 1 in 100 people who take the medicine, according to regulatory data.


Q: Do official sources list any symptoms that require immediate medical attention while on this drug?

Yes. Regulatory documents list severe, life-threatening events such as anaphylaxis (a serious allergic reaction), Stevens-Johnson syndrome (SJS), and Toxic Epidermal Necrolysis (TEN) as very rare reactions. These events are considered critical and indicate a need for prompt medical assessment.


Q: How long does it typically take for Amoxicillin STADA to start having an effect?

Pharmacokinetic data from regulatory sources indicates that the medicine is rapidly absorbed after being taken orally. It typically reaches its peak concentration in the bloodstream within approximately one to two hours after a dose.


Q: Is Amoxicillin STADA the same as Amoxil?

Amoxicillin STADA and Amoxil are both trade names for the same generic medicine, amoxicillin. They contain the identical active ingredient but are marketed by different manufacturers under different brand names, which is common for prescription medications.


Q: What happens if a dose of Amoxicillin STADA is missed?

Official instructions note that a missed dose may be taken as soon as it is remembered, unless the time for the next scheduled dose is imminent. In that case, the missed dose should be skipped. It is specified that the dose should not be doubled to make up for the missed one.


Q: What should be done if an interaction with another drug is suspected?

Regulatory labeling states that if a patient experiences any sign of a severe allergic reaction or other serious adverse events, the product labeling advises that use of the medicine be discontinued. Official information indicates that a doctor or pharmacist should be contacted.


Q: Why is it important to complete the full course of Amoxicillin STADA as prescribed?

It is necessary to complete the full prescribed course to help ensure the infection is completely eliminated and to reduce the development of drug-resistant bacteria. This instruction is emphasized in official labeling, even if symptoms show improvement before the course is finished.


Q: Does Amoxicillin STADA interact with alcohol?

Official regulatory documents generally do not list a specific formal interaction between this medicine and alcohol. Regulatory documents do not detail whether consumption may worsen common side effects like nausea or digestive upset.


Q: Can Amoxicillin STADA be used for dental infections?

Yes, official regulatory indications for amoxicillin include the treatment of infections associated with the teeth and gums. Specifically, it is indicated for treating a dental abscess that has resulted in spreading cellulitis.


Q: Do official prescribing documents mention anything about driving while taking Amoxicillin STADA?

Formal studies on the ability to drive have not been performed, but official documents mention that the drug may influence the ability to drive or use heavy machinery. This is because side effects such as dizziness and, in rare cases, convulsions are possible.


Q: Can Amoxicillin STADA lead to secondary infections like thrush?

Yes. Official documents list mucocutaneous candidosis as a common adverse reaction. This condition, which is also referred to as thrush or yeast infection, can occur due to the medicine's effect on the balance of organisms in the body.


Q: What is the relationship between Amoxicillin STADA and the gut microbiome?

While official documents do not use the term 'gut microbiome,' the regulatory data confirms the medicine's effect on intestinal flora. This is evidenced by the listing of common gastrointestinal disorders like diarrhea and the serious potential for antibiotic-associated colitis, which are consequences of disrupting intestinal flora.


Q: How quickly does Amoxicillin STADA leave the system?

According to pharmacokinetic data, the amount of time it takes for half the drug to be eliminated from the body, known as the half-life, is approximately 61.3 minutes in adults who have normal kidney function. This measure indicates how quickly the drug is cleared from the system.


Q: Why is Amoxicillin STADA sometimes used in combination with other drugs?

Amoxicillin is used in combination therapy with other specific agents (such as clarithromycin) for the official treatment and eradication of the bacterium Helicobacter pylori (H. pylori) in the stomach.


Q: Is Amoxicillin STADA effective against H. pylori?

Yes. Amoxicillin is specifically indicated in official documents for use against Helicobacter pylori infection. It is prescribed as part of a multi-drug regimen (dual or triple therapy) for the purpose of eliminating the bacteria.


Q: Does Amoxicillin STADA have any known effects on mood or sleep?

Official regulatory documents note that the very rare occurrence of reversible hyperactivity and agitation has been reported in the psychiatric disorders category. There is no explicit mention of common effects on general mood or sleep patterns.


Q: Is it true that Amoxicillin STADA can be used for Lyme disease?

Yes, official regulatory indications list amoxicillin for the treatment of Lyme disease. It is typically indicated for specific manifestations of the disease, particularly in the earlier stages.


Q: Can I take ibuprofen or paracetamol with Amoxicillin STADA?

The official drug interaction lists provided by regulatory agencies do not document a formal interaction between Amoxicillin and common pain relievers such as ibuprofen or paracetamol (acetaminophen).


Q: What is the difference in purpose between Amoxicillin and Amoxicillin-clavulanic acid combinations?

The combination is used to expand the drug's effectiveness. The added clavulanic acid acts to inhibit beta-lactamase enzymes, which are produced by some bacteria to destroy Amoxicillin. By protecting the amoxicillin, the combination is able to treat infections caused by a wider range of resistant bacteria.

How should Amoxicillin STADA be stored and disposed of?

How to Store and Dispose of Amoxicillin STADA

Storage and disposal must strictly follow the requirements set by regulatory labeling to maintain the medicine’s quality and protect the environment.


Official Storage Requirements

Condition Requirement
Temperature Store dry capsules or powder at room temperature, typically 20 C to 25 C.
Protection Keep the medicine out of the sight and reach of children. Protect dry forms from excess heat and moisture.
Packaging Keep the product in its original container and the bottle tightly closed.

Stability and Disposal

Once the powder is mixed to create the liquid suspension, it must be discarded after 14 days; the liquid form must not be frozen.

Expired or unused Amoxicillin STADA should not be disposed of via household waste or wastewater. Patients must consult a pharmacist for instructions on how to dispose of the product according to local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Amoxicillin STADA found in:

A-Z Index: